Dr. Alan Zajarias, MD
Claim this profileWashington University in St. Louis
Studies Mitral Regurgitation
Studies Mitral Valve Regurgitation
7 reported clinical trials
9 drugs studied
Affiliated Hospitals
Clinical Trials Alan Zajarias, MD is currently running
Transcatheter Valve Repair
for Mitral Regurgitation
This trial tests a new device called Edwards PASCAL that fixes leaky heart valves without surgery. It is for patients who can't have surgery or haven't improved with other treatments. The device helps the valve close better, stopping blood from leaking backward.
Recruiting1 award N/A9 criteria
TMVR
for Mitral Valve Regurgitation
Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device.
Recruiting1 award N/A
More about Alan Zajarias, MD
Clinical Trial Related6 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Alan Zajarias, MD has experience with
- Edwards PASCAL System
- Optimal Medical Therapy
- Edwards SAPIEN 3/SAPIEN 3 Ultra THV
- Edwards SAPIEN 3 THV
- Edwards SAPIEN 3 Transcatheter Valve, Model 9600TFX
- SAPIEN 3 THV
Breakdown of trials Alan Zajarias, MD has run
Mitral Regurgitation
Mitral Valve Regurgitation
Aortic Valve Stenosis
Mitral Valve Disease
Heart Failure
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Alan Zajarias, MD specialize in?
Is Alan Zajarias, MD currently recruiting for clinical trials?
Are there any treatments that Alan Zajarias, MD has studied deeply?
What is the best way to schedule an appointment with Alan Zajarias, MD?
What is the office address of Alan Zajarias, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.